Whilst inhibition of COX-2 expression is reported to reduce generation of reactive oxygen species and prevent DNA damage, recent studies show that COX-2 inhibitors celecoxib [55] and sulindac [56], induce reactive oxygen species to mediate anti-tumour responses. The gene discussed is PTGS2; the disease is neoplasm.